accountIn the Region FTC: Outlaw 'pay for delay' drug deals The Federal Trade Commission urged an appeals court in Philadelphia to outlaw settlements between brand drug makers and generic-drug makers on patent expirations. The...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Business news in brief
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account